AFMD - Affimed N.V.
IEX Last Trade
1.29
-0.010 -0.775%
Share volume: 2,382
Last Updated: Fri 27 Dec 2024 08:28:52 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.01
-0.77%
Summary score
29%
Profitability
25%
Dept financing
15%
Liquidity
71%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.12%
Return on assets
-12.52%
Return on sales
0%
Return on invested capital
301.82%
Total debt ratio
39.91%
Debt ratio change over timeo
-0.64%
Current Ratio
5%
Quick Ratio
4.97%
Cash Position Ratio
4.2%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-34.85%
Return on assets
-11.48%
Return on sales
0%
Return on invested capital
41.75%
Total debt ratio
66.85%
Debt ratio change over timeo
0.6%
Current Ratio
2.81%
Quick Ratio
2.8%
Cash Position Ratio
2.43%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-29.63%
Return on assets
-11.02%
Return on sales
0%
Return on invested capital
45.43%
Total debt ratio
59.96%
Debt ratio change over time
1.07%
Current Ratio
2.93%
Quick Ratio
2.91%
Cash Position Ratio
2.6%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-121.46%
Return on assets
-110.36%
Return on sales
0%
Return on invested capital
75.52%
Total debt ratio
-64.41%
Debt ratio change over time
-0.64%
Current Ratio
2.69%
Quick Ratio
2.67%
Cash Position Ratio
2.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AFMD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -22.12% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.52% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 301.82% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 59% |
| Total debt ratio | 39.91% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.64% | 6.09% | 6.03% | 1.53% |
| Dept financing | 10% | 50% | 43% | 14% |
| Current Ratio | 2.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 2.8% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.43% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 19% | 38% | 41% |
| Short-term ratios | AFMD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -34.85% | -25.62% | 17.94% | 7.14% |
| Return on assets | -11.48% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 41.75% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 43% | 74% | 68% |
| Total debt ratio | 66.85% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | 0.6% | -23.44% | 9.66% | 0.6% |
| Dept financing | 17% | 25% | 45% | 8% |
| Current Ratio | 2.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 2.8% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.43% | 1.48% | 0.76% | 1.49% |
| Liquididy | 69% | 47% | 37% | 65% |